Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110845341B reveals a high-yield, low-toxicity route for Chlorantraniliprole intermediates, offering significant cost reduction and supply chain reliability.
Patent CN120117998A reveals cost-effective route for apalutamide intermediate ensuring supply chain stability and reduced manufacturing complexity for global buyers.
Patent CN108640945B reveals a novel Ru/Ir-catalyzed direct C-H alkynylation of amides. This method eliminates directing groups, offering cost-effective routes for high-purity pharmaceutical intermediates.
Novel nickel-catalyzed oxidation route for Acalabrutinib key intermediate reduces cost and pollution while ensuring high purity for pharma supply chains.
Patent CN113563305B reveals a cost-effective, high-yield route for 2-(4-phenoxyphenyl)-6-(N-substituted oxycarbonyl piperidine-4-) nicotinamide, ensuring reliable supply chain stability.
Patent CN102356063B details a safe synthesis route for quinoline intermediates. This method avoids hazardous azides ensuring high purity and supply chain reliability for pharmaceutical production.
Novel chloroacetamide-based method reduces side reactions and costs for PDE5 inhibitor intermediates, offering scalable supply chain solutions.
Patent CN114249668B reveals safer PPTS catalysis for Zolpidem intermediate. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN102584509A reveals a green iodide-catalyzed amide synthesis. Discover cost-effective manufacturing solutions for high-purity pharmaceutical intermediates.
Novel hypochlorite oxidation method for Bicalutamide intermediate reduces cost and pollution. Reliable supply chain partner for scalable pharmaceutical intermediate manufacturing.
Novel catalytic method enhances benzamide compound purity and yield. Offers significant supply chain stability and cost reduction in API manufacturing for global partners.
Novel patent CN119161318A offers mild benzopyran amide synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Novel palladium-catalyzed method reduces costs and improves supply chain reliability for high-purity pharmaceutical intermediates using nitroarenes.
Novel one-pot Suzuki coupling method for Darolutamide intermediate. Eliminates column chromatography, reduces cost, ensures supply continuity for pharmaceutical manufacturing.
Novel scalable route for tegoprazan key intermediate offering high purity ≥99% and simplified post-processing for reliable pharmaceutical supply chains.
Patent CN114539198A details a novel Pd-catalyzed route to isochroman amides using nitroarenes, offering safer scale-up and cost reduction in pharmaceutical intermediate manufacturing.
Novel one-step synthesis of benzofuran-3-carboxamides using Pd-catalyzed carbonylation. Offers high efficiency and substrate compatibility for pharmaceutical intermediates.
Patent CN103153956A details a novel route for kinase inhibitor intermediates using Suzuki-Miyaura coupling, offering enhanced safety and yield for pharmaceutical manufacturing.
Patent CN114539198B reveals a novel Pd-catalyzed route for chroman amides, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed method for benzopyran amides. Reduces waste, uses nitro sources. Reliable supply for pharmaceutical manufacturing.